
Oils
Primobolan 100mg
Methenolone Enanthate, a mild DHT-derived compound prized for lean-tissue quality; verified at 99% purity.
Primobolan (Methenolone Enanthate) is a DHT-derived injectable long studied for a favourable ratio of anabolic benefit to side effects, valued in research for lean-tissue preservation with minimal androgenic or oestrogenic activity. Each 10ml vial is supplied at 100mg/ml. This batch was independently verified at 99% raw-material purity, with the finished vial assayed at 107.22mg/ml — roughly 107% of the 100mg/ml label claim.
Specifications
Research Benefits
- Lean muscle preservation — Studied for maintaining quality tissue during caloric restriction research.
- No aromatisation — Does not convert to oestrogen, avoiding water retention.
- Low androgenic activity — One of the mildest injectable anabolic profiles studied in the literature.
- Steady, gradual gains — Associated with slow, well-retained lean tissue accrual rather than rapid mass.
- Verified potency — Independently confirmed at 99% raw purity and 107.22mg/ml finished content.
How It Works
Its anabolic activity works primarily through enhanced nitrogen retention and protein synthesis, with comparatively low androgenic signalling relative to its anabolic effect — the property most cited in research discussing its favourable tolerability. The enanthate ester's 10-14 day half-life supports twice-weekly dosing.
⚠ For Research Use Only
By purchasing, the buyer confirms this product is being acquired for legitimate research purposes and assumes full responsibility for its handling, storage, and use in compliance with all applicable local, national, and international laws.
More Oils

Oils
Boldenone Undecylenate (EQ)
Equipoise, a long-acting testosterone derivative studied for lean gains, endurance and red blood cell increases.
View
Oils
DHB (1-Testosterone)
Dihydroboldenone, a potent non-aromatising DHT-class compound studied for lean mass and strength research.
View
Oils
Fem-Test
A low-dose 10mg/ml testosterone formulation designed for female-specific research dosing protocols.
View